Anyone interested in oncology and proton therapy may find the upcoming symposium on The Promises and Perils of Proton Radiotherapy a must-attend event. The symposium is scheduled for May 8-9 in Baltimore.

Proton therapy is the recommended and safer treatment to target smaller tumors. It reduces exposure to healthy tissue thus lowering the risk of secondary cancer. Since facilities offering this modality are increasing, practitioners will want to keep up to date.

The American Association of Physicists in Medicine (AAPM) sponsors the symposium which will feature a panel of public health, clinical and research experts who will debate the potential and disadvantages of proton therapy including best practices, medical equipment, clinical trials and controversies. Among those participating on the panel will be Dr. Eric Klein, Washington University, MO; Dr. Christopher Rose, Valley Radiotherapy Associates Medical Group, CA; and Dr. Jatinder Palta, University of Florida Health Science Center, FL.
The AAPM is an educational, professional organization serving patients, physicians and physicists. It encourages research, assists dissemination of scientific and technical information and promotes high quality medical services.

Visit The Promises and Perils of Proton Radiotherapy for more details and registration information.

Watch for a report on proton therapy in the May 2009 issue of DOTmed Business News.